Protective association of Klotho rs495392 gene polymorphism against hepatic steatosis in non-alcoholic fatty liver disease patients

키워드

참고문헌 (55)

1. Brunt EM, "Nonalcoholic fatty liver disease", Nat Rev Dis Primers, 1, pp.15080~ (2015)
2. Masuoka HC, "Nonalcoholic fatty liver disease : an emerging threat to obese and diabetic individuals", Ann N Y Acad Sci, 1281, pp.106~122 (2013)
3. Younossi Z, "Global burden of NAFLD and NASH : trends, predictions, risk factors and prevention", Nat Rev Gastroenterol Hepatol, 15, pp.11~20 (2018)
4. Trépo E, "Update on NAFLD genetics : from new variants to the clinic", J Hepatol, 72, pp.1196~1209 (2020)
5. Romeo S, "Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease", Nat Genet, 40, pp.1461~1465 (2008)
6. Razzaque MS, "The role of klotho in energy metabolism", Nat Rev Endocrinol, 8, pp.579~587 (2012)
7. Martin A, "Regulation and function of the FGF23", klotho endocrine pathways, 2012, pp.92, 131~155
8. Matsumura Y, "Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein", Biochem Biophys Res Commun, 242, pp.626~630 (1998)
9. Ohnishi M, "Dietary and genetic evidence for enhancing glucose metabolism and reducing obesity by inhibiting klotho functions", FASEB J, 25, pp.2031~2039 (2011)
10. Kawano K, "Klotho gene polymorphisms associated with bone density of aged postmenopausal women", J Bone Miner Res, 17, pp.1744~1751 (2002)
11. Luo L, "The klotho gene G-395A polymorphism and metabolic syndrome in very elderly people", BMC Geriatr, 16, pp.46~ (2016)
12. Serafi Cambray, "Association of a single nucleotide polymorphism combination pattern of the Klotho gene with non-cardiovascular death in patients with chronic kidney disease", Clinical Kidney Journal, 13(6), pp.1017~1024 (2020), Oxford University Press (OUP)[DOI]
13. Kim Y, "Klotho is a genetic risk factor for ischemic stroke caused by cardioembolism in Korean females", Neurosci Lett, 407, pp.189~194 (2006)
14. Imamura A, "Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese", Clin Chim Acta, 371, pp.66~70 (2006)
15. Solache-Berrocal G, "CYP24 A1 and KL polymorphisms are associated with the extent of vascular calcification but do not improve prediction of cardiovascular events", Nephrol Dial Transplant, 36, pp.2076~2083 (2021)
16. Valdivielso JM, "Association of the rs495392 klotho polymorphism with atheromatosis progression in patients with chronic kidney disease", Nephrol Dial Transplant, 34, pp.2079~2088 (2019)
17. Westra HJ, "Systematic identification of trans eQTLs as putative drivers of known disease associations", Nat Genet, 45, pp.1238~1243 (2013)
18. Pacifico L, "Association between vitamin D levels and nonalcoholic fatty liver disease : potential confounding variables", Mini Rev Med Chem, 19, pp.310~332 (2019)
19. Zhang Z, "Vitamin D and nonalcoholic fatty liver disease", Curr Opin Clin Nutr Metab Care, 22, pp.449~458 (2019)
20. Li R, "1, 25(OH)2D3 attenuates hepatic steatosis by inducing autophagy in mice", Obesity(Silver Spring), 25, pp.561~571 (2017)
21. Lee I, "Association of nonalcoholic fatty liver disease with serum vitamin D levels in combination of physical fitness in Korean older adults", J Steroid Biochem Mol Biol, 198, pp.105569~ (2020)
22. Forster RE, "Vitamin D receptor controls expression of the antiaging klotho gene in mouse and human renal cells", Biochem Biophys Res Commun, 414, pp.557~562 (2011)
23. Liu WY, "Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease", J Gastroenterol Hepatol, 35, pp.1057~1064 (2020)
24. Matthews DR, "Homeostasis model assessment : insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man", Diabetologia, 28, pp.412~419 (1985)
25. Sumner AE, "Ethnic differences in the ability of triglyceride levels to identify insulin resistance", Atherosclerosis, 196, pp.696~703 (2008)
26. American Diabetes Association, "1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2020", Diabetes Care, 43(Supplement_1), pp.S7~S13 (2019), American Diabetes Association[DOI]
27. Kleiner DE, "Design and validation of a histological scoring system for nonalcoholic fatty liver disease", Hepatology, 41, pp.1313~1321 (2005)
28. Ikram MA, "Objectives, design and main findings until 2020 from the Rotterdam study", Eur J Epidemiol, 35, pp.483~517 (2020)
29. Bedogni G, "The fatty liver index : a simple and accurate predictor of hepatic steatosis in the general population", BMC Gastroenterol, 6, pp.33~ (2006)
30. Petta S, "The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease", Hepatology, 62, pp.1101~1110 (2015)
31. 1000 Genomes Project Consortium, "A global reference for human genetic variation", Nature, 526, pp.68~74 (2015)
32. Nie F, "Serum klotho protein levels and their correlations with the progression of type 2diabetes mellitus", J Diabetes Complications, 31, pp.594~598 (2017)
33. Amitani M, "Plasma klotho levels decrease in both anorexia nervosa and obesity", Nutrition, 29, pp.1106~1109 (2013)
34. Lin Y, "Antiaging gene klotho attenuates pancreatic β-cell apoptosis in type 1 diabetes", Diabetes, 64, pp.4298~4311 (2015)
35. Rao Z, "Administration of alpha klotho reduces liver and adipose lipid accumulation in obese mice", Heliyon, 5, pp.e01494~ (2019)
36. Chihara Y, "Klotho protein promotes adipocyte differentiation", Endocrinology, 147, pp.3835~3842 (2006)
37. Gu H, "Soluble klotho improves hepatic glucose and lipid homeostasis in type 2 diabetes", Mol Ther Methods Clin Dev, 18, pp.811~823 (2020)
38. Watt MJ, "The liver as an endocrine organ-linking NAFLD and insulin resistance", Endocr Rev, 40, pp.1367~1393 (2019)
39. Rao UK, "Predicting immuno-metabolic complications after allogeneic hematopoietic cell transplant with the cytokine interleukin-33(IL-33)and its receptor serum-stimulation 2(ST2)", Clin Hematol Int, 2, pp.101~108 (2020)
40. Kurosu H, "Suppression of aging in mice by the hormone klotho", Science, 309, pp.1829~1833 (2005)
41. Kuro-o M, "Mutation of the mouse klotho gene leads to a syndrome resembling ageing", Nature, 390, pp.45~51 (1997)
42. Landry T, "Central α-klotho suppresses NPY", AgRP neuron activity and regulates metabolism in mice, 2020, pp.69, 1368~1381
43. Landry T, "Centrally circulating α-klotho inversely correlates with human obesity and modulates arcuate cell populations in mice", Mol Metab, 44, pp.101136~ (2021)
44. Yamashita D, "Mechanism for the action of PPARs", Nihon Rinsho, 63, pp.536~537 (2005)
45. Kuro-O M, "The Klotho proteins in health and disease", Nat Rev Nephrol, 15, pp.27~44 (2019)
46. Rearick D, "Critical association of ncRNA with introns", Nucleic Acids Res, 39, pp.2357~2366 (2011)
47. Yokoyama S, "A klotho gene single nucleotide polymorphism is associated with the onset of stroke and plasma klotho concentration", Aging(Albany NY), 11, pp.104~114 (2018)
48. Tomiyama K, "Relevant use of klotho in FGF19 subfamily signaling system in vivo", Proc Natl Acad Sci U S A, 107, pp.1666~1671 (2010)
49. Barchetta I, "Strong association between non alcoholic fatty liver disease(NAFLD)and low 25(OH)vitamin D levels in an adult population with normal serum liver enzymes", BMC Med, 9, pp.85~ (2011)
50. Targher G, "Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease", Nutr Metab Cardiovasc Dis, 17, pp.517~524 (2007)
51. He X, "The association of serum FGF23 and non-alcoholic fatty liver disease is independent of vitamin D in type 2 diabetes patients", Clin Exp Pharmacol Physiol, 45, pp.668~674 (2018)
52. Young Hoon Choi, "Association Between Vitamin D Deficiency and Suspected Nonalcoholic Fatty Liver Disease in an Adolescent Populatio", Pediatric Gastroenterology, Hepatology & Nutrition, 22(3), pp.233~241 (2019), 대한소아소화기영양학회[DOI]
53. Jaruvongvanich V, "Vitamin D and histologic severity of nonalcoholic fatty liver disease : a systematic review and meta-analysis", Dig Liver Dis, 49, pp.618~622 (2017)
54. Saberi B, "Vitamin D levels do not predict the stage of hepatic fibrosis in patients with non-alcoholic fatty liver disease : a PRISMA compliant systematic review and meta-analysis of pooled data", World J Hepatol, 10, pp.142~154 (2018)
55. Keane JT, "Vitamin D and the liver-correlation or cause?", Nutrients, 10, pp.496~ (2018)

관련 논문AI추천